Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

Ingrid S. van Maurik*, Stephanie J. Vos, Isabelle Bos, Femke H. Bouwman, Charlotte E. Teunissen, Philip Scheltens, Frederik Barkhof, Lutz Frolich, Johannes Kornhuber, Jens Wiftfang, Wolfgang Maier, Oliver Peters, Eckart ROther, Flavio Nobili, Giovanni B. Frisoni, Luiza Spiru, Yvonne Freund-Levi, Asa K. Wallin, Harald Hampel, Hilkka SoininenMagda Tsolaki, Frans Verhey, Iwona Kloszewska, Patrizia Mecocci, Bruno Vellas, Simon Lovestone, Samantha Gailuzzi, Sanna-Kaisa Herukka, Isabel Santana, Ines Baldeiras, Alexandre de Mendonca, Dina Silva, Gael Chetelat, Stephanie Egret, Sebastian Palmqvist, Oskar Hansson, Pieter Jelle Visser, Johannes Berkhof, Wiesje M. van der Flier, Alzheimer's Disease Neuroimaging Initiative

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1034-1044
Number of pages11
JournalLancet Neurology
Volume18
Issue number11
DOIs
Publication statusPublished - Nov 2019

Keywords

  • ALZHEIMERS-DISEASE
  • CSF BIOMARKERS
  • DEMENTIA
  • PROGRESSION
  • DIAGNOSIS

Cite this

van Maurik, I. S., Vos, S. J., Bos, I., Bouwman, F. H., Teunissen, C. E., Scheltens, P., Barkhof, F., Frolich, L., Kornhuber, J., Wiftfang, J., Maier, W., Peters, O., ROther, E., Nobili, F., Frisoni, G. B., Spiru, L., Freund-Levi, Y., Wallin, A. K., Hampel, H., ... Alzheimer's Disease Neuroimaging Initiative (2019). Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. Lancet Neurology, 18(11), 1034-1044. https://doi.org/10.1016/S1474-4422(19)30283-2